TrialThe oncologist2021

Radium-223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results.

Benjamin L Maughan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.